Free Trial

AngioDynamics (ANGO) Earnings Date, Estimates & Call Transcripts

$7.18
+0.23 (+3.31%)
(As of 04:31 PM ET)

Earnings Summary

Upcoming
Earnings Date
Oct. 2Estimated
Actual EPS
(Jul. 16)
-$0.06 Beat By $0.11
Consensus EPS
(Jul. 16)
-$0.17
Skip Charts & View Estimated and Actual Earnings Data

ANGO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANGO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AngioDynamics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243($0.14)$0.00($0.09) 
Q2 20243($0.08)$0.03($0.04) 
Q3 20243($0.15)$0.03($0.08) 
Q4 20243($0.21)$0.09($0.07) 
FY 202412($0.58)$0.15($0.29) 
Q1 20252($0.19)($0.13)($0.16) 
Q2 20252($0.15)($0.10)($0.13) 
Q3 20252($0.16)($0.10)($0.13) 
Q4 20252($0.09)($0.07)($0.08) 
FY 20258($0.59)($0.40)($0.50) 
Q1 20261($0.18)($0.18)($0.18) 
Q2 20261($0.08)($0.08)($0.08) 
Q3 20261($0.02)($0.02)($0.02) 

ANGO Earnings Date and Information

AngioDynamics last issued its quarterly earnings results on July 16th, 2024. The medical instruments supplier reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.17) by $0.11. The company had revenue of $71 million for the quarter, compared to analysts' expectations of $70.86 million. Its revenue was down 22.1% compared to the same quarter last year. AngioDynamics has generated ($4.84) earnings per share over the last year (($4.84) diluted earnings per share). Earnings for AngioDynamics are expected to grow in the coming year, from ($0.40) to ($0.29) per share. AngioDynamics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 2nd, 2024 based off prior year's report dates.

AngioDynamics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/2/2024
(Estimated)
------- 
7/16/2024Q4 2024($0.17)($0.06)+$0.11$0.21$70.86 million$71.00 million    
4/4/2024Q3 2024($0.14)($0.16)($0.02)$4.41$76.71 million$75.18 million
1/5/2024Q2 2024($0.09)($0.05)+$0.04$0.62$81.65 million$79.07 million
10/4/2023Q1 2024($0.13)($0.12)+$0.01($1.39)$77.70 million$78.70 million    
7/12/2023Q2 2023$0.02$0.02-$0.58$90.73 million$91.10 million    
3/30/2023Q3 2023($0.01)($0.03)($0.02)$0.18$83.20 million$80.70 million    
1/5/2023Q2 2023($0.01)$0.01+$0.02$0.23$84.05 million$85.43 million
10/6/2022Q1 2023($0.02)($0.06)($0.04)$0.21$83.43 million$81.50 million    
7/12/2022Q4 2022$0.01$0.01-$0.18$82.91 million$87.00 million    
4/7/2022Q3 2022($0.01)$0.03+$0.04$0.19$76.32 million$74.00 million    
1/5/2022Q4 2021$0.0050($0.02)($0.0250)$0.17$77.90 million$78.30 million    
9/30/2021Q3 2021($0.05)($0.02)+$0.03$0.14$71.31 million$77.00 million    
3/29/2021Q1 2021($0.02)$0.02+$0.04$0.13$68.42 million$71.18 million    
1/6/2021Q4 2020($0.02)$0.01+$0.03$0.13$67.33 million$72.80 million    
10/4/2020Q3 2020($0.07)$0.02+$0.09$0.15$65.10 million$70.20 million    
7/16/2020Q2 2020($0.06)($0.06)-$3.98$62.86 million$58.30 million  
4/7/2020Q1 2020($0.03)$0.01+$0.04$0.17$68.55 million$69.80 million    
1/7/2020Q2 2020$0.02$0.06+$0.04$0.19$71.28 million$70.00 million    
10/3/2019Q1 2020$0.04$0.08+$0.04$0.19$67.74 million$66.00 million    

AngioDynamics Earnings - Frequently Asked Questions

When is AngioDynamics's earnings date?

AngioDynamics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 2nd, 2024 based off last year's report dates. Learn more on ANGO's earnings history.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY 2025 earnings guidance on Tuesday, July, 16th. The company provided earnings per share guidance of -0.420--0.380 for the period, compared to the consensus estimate of -0.490. The company issued revenue guidance of $282.0 million-$288.0 million, compared to the consensus revenue estimate of $287.3 million.

Did AngioDynamics beat their earnings estimates last quarter?

In the previous quarter, AngioDynamics (NASDAQ:ANGO) reported ($0.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.11. Learn more on analysts' earnings estimate vs. ANGO's actual earnings.

How can I listen to AngioDynamics's earnings conference call?

The conference call for AngioDynamics's latest earnings report can be listened to online. Listen to Conference Call

How can I read AngioDynamics's conference call transcript?

The conference call transcript for AngioDynamics's latest earnings report can be read online. Read Transcript

How much revenue does AngioDynamics generate each year?

AngioDynamics (NASDAQ:ANGO) has a recorded annual revenue of $303.91 million.

How much profit does AngioDynamics generate each year?

AngioDynamics (NASDAQ:ANGO) has a recorded net income of -$52.44 million. ANGO has generated -$4.84 earnings per share over the last four quarters.

What is AngioDynamics's EPS forecast for next year?

AngioDynamics's earnings are expected to grow from ($0.40) per share to ($0.29) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ANGO) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners